FNY Managed Accounts’s Select Medical SEM Stock Holding History

FNY Managed Accounts’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-8,708	Closed	-$90K	–	794
2017 Q3	$90K	Buy	+8,708	New	+$80.4K	0.12%	109

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FNY Managed Accounts's SEM Position: Q4 2017 in Review

FNY Managed Accounts sold out of Select Medical (SEM) in Q4 2017, closing a stake of 8,708 shares — an estimated $90K sold.

FNY Managed Accounts first reported a position in SEM in Q3 2017 and held it in 1 quarter. The position peaked at $90K in Q3 2017. 184 funds tracked by Wall St. Rank hold SEM as of Q4 2017.

FNY Managed Accounts reported no remaining Select Medical position as of Q4 2017 after selling out during the quarter.
FNY Managed Accounts sold 8,708 Select Medical shares in Q4 2017, an estimated $90K.
FNY Managed Accounts first reported a position in Select Medical in Q3 2017 and held it in 1 quarter.
FNY Managed Accounts's Select Medical position peaked at $90K in Q3 2017.
184 funds tracked by Wall St. Rank held Select Medical as of Q4 2017.

Based on FNY Managed Accounts's 13F filing for Q4 2017, filed 23 Jan 2018.